alnylam pharmaceuticals inc
(ALNY:Consolidated Issue Listed on NASDAQ Global Select )
Head of Commercial and Vice President, Alnylam Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 1 different industries.|
Mr. Oved Amity has been the Head of Commercial and Vice President at Alnylam Pharmaceuticals, Inc. since June 2012. Before joining Alnylam, Mr. Amity served as Vice President for Strategic Development for the Personalized Genetic Health business unit at Genzyme Corporation, now a Sanofi company. At Genzyme, he led the internal research and development activities for their rare diseases franchise. Prior to this position he served as General Manager of the Gaucher Disease ...
300 Third StreetPhone: 617-551-8200
Cambridge, Massachusetts 02142
Board Members Memberships*There is no Board Members Memberships data available.
Hebrew University of Jerusalem
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Stanley T. Crooke M.D., Ph.D.||Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee|
Isis Pharmaceuticals, Inc.
|Ali Mortazavi||Chief Executive and Director|
Silence Therapeutics plc
|Edward M. Kaye M.D., Ph.D.||Interim Chief Executive Officer, Chief Medical Officer and Senior Vice President|
Sarepta Therapeutics, Inc.
|Mark Joseph Murray Ph.D.||Chief Executive Officer, President and Director|
Tekmira Pharmaceuticals Corporation
|Paul C. Grint M.D.||Chief Executive Officer, President and Director|
Regulus Therapeutics Inc.
|--||Compensation as of Fiscal Year 2014.|